With the average cost of developing a new drug at approximately $2.3 billion, streamlining and automating the clinical trial process is a perfect use case for AI. In this webcast from Modus Create, featuring a life sciences industry analyst from IDC, you’ll discover how AI and GenAI can transform the clinical trial process to improve clinical outcomes and accelerate time-to-market.